Table 4 |
|||||||||||||||
|
Baseline characteristics and outcomes in intervention and control groups in 14 studies included in meta-analysis |
|||||||||||||||
|
Author: |
Year |
Creatinine* |
Urea* |
APACHE II score |
Dialysis-Free (%) |
Duration of RRT (days) |
ICU Length of Stay (days) |
Mortality at 28-days (%) |
|||||||
|
|
|
|
|
|
|
|
|||||||||
|
Early |
Late |
Early |
Late |
Early |
Late |
Early |
Late |
Early |
Late |
Early |
Late |
Early |
Late |
||
|
|
|||||||||||||||
|
Bouman [10] |
2002 |
5 (4)** |
6 (4)** |
NR |
NR |
21.7(5.5) |
23.6(8.3) |
17 |
22 |
5.7 |
6.6 |
NR |
NR |
11/35 |
9/36 |
|
Sugahara [32] |
2004 |
256 |
265 |
NR |
NR |
19(2) |
18(3) |
10 |
2 |
NR |
NR |
NR |
NR |
2/14 |
12/14 |
|
Liu [21] |
2006 |
301 |
415 |
16.9 |
41.0 |
NR |
NR |
NR |
NR |
NR |
NR |
NR |
NR |
43/122 |
50/121 |
|
Sabater [33] |
2008 |
NR |
NR |
NR |
NR |
24(8) |
29(9) |
NR |
NR |
6 |
7 |
NR |
NR |
1/9 |
16/23 |
|
Bagshaw [34] |
2009 |
230 |
396 |
15.0 (5.4) |
38.8 (12) |
11.1 (3)§ |
10.7 (3)§ |
91 |
74 |
4 (2-13) |
6 (2-15) |
13 (7-24) |
13 (6-28) |
392/618 |
380/619 |
|
Bagshaw [35] |
2010 |
273 |
489 |
13.5 |
38.0 |
31(9.3) |
28.1(6.7) |
22 |
30 |
NR |
NR |
12 |
14 |
67/117 |
54/117 |
|
Gettings [15] |
1999 |
148 |
238 |
15.2 (4.6) |
33.7 (10) |
NR |
NR |
16 |
11 |
17.7 |
20.2 |
NR |
NR |
25/41 |
47/59 |
|
Elahi [38] |
2004 |
328 |
379 |
23.9 (12) |
26.8 (22) |
NR |
NR |
NR |
NR |
4.61 |
4.57 |
8.5 |
12.5 |
8/28 |
12/36 |
|
Dermirkilic [13] |
2004 |
NR |
NR |
NR |
NR |
NR |
NR |
NR |
NR |
4.32 |
4.56 |
7.8 |
12.4 |
8/27 |
15/34 |
|
Andrade [36] |
2007 |
583 |
548 |
73.9 (6.6) |
82.8 (6.9) |
24.5 (1.4) |
26 (1.2) |
NR |
NR |
NR |
NR |
20 |
13.6 |
3/18 |
10/15 |
|
Wu [42] |
2007 |
256 |
415 |
16.5 (7) |
42.4 (12) |
18.2 (5.1) |
20.5 (5.3) |
NR |
NR |
NR |
NR |
NR |
NR |
34/54 |
22/26 |
|
Manche [40] |
2008 |
233 |
404 |
14.4 (3.1) |
35.2 (18) |
NR |
. |
NR |
NR |
1.8 |
6.5 |
NR |
NR |
14/56 |
13/15 |
|
Iyem [39] |
2009 |
186 |
256 |
19.5 (2.7) |
24.3 (1.9) |
NR |
. |
95 |
87 |
1.6 |
4.1 |
2 |
4 |
5/95 |
6/90 |
|
Shiao [41] |
2009 |
292 |
336 |
24.6 (14) |
29.2 (14) |
18.2 (5.4) |
18.8 (6.3) |
21 |
10 |
NR |
NR |
NR |
NR |
22/51 |
35/47 |
|
Carl [37] |
2010 |
442 |
514 |
23.6 (7.2) |
48.9 (10) |
24.8 (6.2) |
24.7 (6.1) |
NR |
NR |
NR |
NR |
27 |
39.1 |
44/85 |
42/62 |
|
|
|||||||||||||||
|
* Continuous variables reported as means and standard deviations when given. ** Bouman et al. reported creatinine clearance (ml/minute). |
|||||||||||||||
|
Karvellas et al. Critical Care 2011 15:R72 doi:10.1186/cc10061 |
|||||||||||||||
